Literature DB >> 10671666

A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.

Y Shimauchi1, M Tanaka, R Kuromatsu, R Ogata, Y Tateishi, S Itano, N Ono, S Yutani, H Nagamatsu, S Matsugaki, S Yamasaki, K Tanikawa, M Sata.   

Abstract

To elucidate the risk factors for developing hepatocellular carcinoma (HCC) during the follow-up of patients with liver cirrhosis (LC), outpatients with LC were examined periodically by means of serum biochemical assessments, ultrasonography, and computed tomography. Risk factors for HCC were statistically analyzed. We also examined an efficacy of Lens culinaris agglutinin A-reactive profiles of alpha-fetoprotein (AFP-L3%) and des-gamma-carboxy prothrombin (DCP) value using a highly sensitive DCP determination kit (ED036) for the early recognition of HCC. The AFP-L3% and the ED036 value were retrospectively determined with stored serum samples. HCC was diagnosed in 21 of the 78 patients with LC during the follow-up period (mean follow-up period: 42 months). The estimated cumulative incidence of HCC was 25% with 3 years and 48% with 5 years. The most significant risk factor for the development of HCC in LC patients was found to be the mean serum AFP concentration from the year before the HCC detection (p=0.02). At the time of the recognition of HCC, the positive rates of the tumor markers were: serum AFP concentration 14%, serum DCP value 5%, AFP-L3% was 33%, and that of ED036 43%. The positive rate in collaborative use of AFP-L3% and ED036 was 67%. The simultaneous determination of the AFP-L3% and the ED036 value was shown to be effective for the early detection of HCC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671666     DOI: 10.3892/or.7.2.249

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  26 in total

1.  Primary hepatocellular carcinoma detected long after tumor markers and lymph node metastases--beyond our vision?

Authors:  Jee-Fu Huang; Kenichi Takayasu; Shuichi Okada; Kazuaki Shimada; Yukihiro Nakanishi; Masafumi Ikeda
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

Review 2.  Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Kiyoshi Hasegawa; Yasuhiko Sugawara; Wei Tang
Journal:  Liver Cancer       Date:  2013-01       Impact factor: 11.740

Review 3.  Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.

Authors:  Pei-Pei Song; Ju-Feng Xia; Yoshinori Inagaki; Kiyoshi Hasegawa; Yoshihiro Sakamoto; Norihiro Kokudo; Wei Tang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.

Authors:  Kristina Tzartzeva; Joseph Obi; Nicole E Rich; Neehar D Parikh; Jorge A Marrero; Adam Yopp; Akbar K Waljee; Amit G Singal
Journal:  Gastroenterology       Date:  2018-02-06       Impact factor: 22.682

5.  Biomarkers for hepatocellular carcinoma.

Authors:  Goshi Shiota; Norimasa Miura
Journal:  Clin J Gastroenterol       Date:  2012-04-26

6.  XAGE-1b expression is associated with the diagnosis and early recurrence of hepatocellular carcinoma.

Authors:  Zeya Pan; Bikui Tang; Zhenyu Hou; Jin Zhang; Hui Liu; Yuan Yang; Gang Huang; Yun Yang; Weiping Zhou
Journal:  Mol Clin Oncol       Date:  2014-07-04

7.  Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

Authors:  Ryosuke Tateishi; Haruhiko Yoshida; Yutaka Matsuyama; Norio Mine; Yuji Kondo; Masao Omata
Journal:  Hepatol Int       Date:  2007-12-29       Impact factor: 6.047

8.  Screening for hepatocellular carcinoma.

Authors:  Singal Amit; Marrero Jorge A
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-03

9.  Serum levels of soluble CD25 as a marker for hepatocellular carcinoma.

Authors:  Roniel Cabrera; Asem I Fitian; Miguel Ararat; Yiling Xu; Todd Brusko; Clive Wasserfall; Mark A Atkinson; Chen Liu; David R Nelson
Journal:  Oncol Lett       Date:  2012-07-26       Impact factor: 2.967

10.  Surveillance and Diagnosis of Hepatocellular Carcinoma.

Authors:  Paul Fitzmorris; Ashwani K Singal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.